Patient P-01724
Synthetic patientNBL-101 · Day 105 · 65–74 · M · baseline S10Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
9%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S10
- Day 36 DT-01 recommended — Dosing / Timing Recommendation DT-01
- Day 37 Patient accepted — Started DT-01 in the companion
- Day 42 GI symptom burden −19% vs expected — Dosing / Timing Recommendation DT-01
- Day 48 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience+7
- GI instability-3
- Toxicity-3
- Inflammatory activity-2
What helped?
- Dosing / Timing Recommendation DT-01Day 36Result: symptom burden −19%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion12/100
worsening · +2.6 vs previous 14 d
Toxicity
Blood19.2/100
stable · +0.3 vs previous 14 d
Sleep quality
Wearable62.3/100
stable · -1.8 vs previous 14 d
Energy level
Daily log7.2/10
stable · -0.1 vs previous 14 d
Stress level
Daily log3.4/10
stable · -0.0 vs previous 14 d
Steps
Wearable3,268
worsening · -144 vs previous 14 d
Adherence
Companion94.3 %
stable · -1.8 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 80 from the failing basin, 17 from restoration.
Good elements to keep
- Dosing / Timing Recommendation DT-01intervention · steering +32.6
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Alcoholperturbation · steering -5.1
- Antibiotic courseperturbation · steering -4.7
- Poor-sleep weekperturbation · steering -3
- Alcoholdetractor · GI +3.2 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+3.2detractor · 95%
- Insoluble fibre-1.4no signal · 40%
- Simple carbohydrates-1.1no signal · 30%
- Dietary fat load+0.3no signal · 15%
- Histamine load+0.2no signal · 15%
- Spicy / capsaicin+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↑20
- Wearable3,268 steps/day
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.2 · butyrate capacity 47/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 7.5 h
- Steps
- 3,202
- Resting HR
- 68 bpm
Daily log: GI score 12, nutritional resilience 73, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.